Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress
Xuemei Gu, Yujuan Shi, Xiaojun Chen, et al.
Phytomedicine (2020) Vol. 78, pp. 153319-153319
Closed Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
Izabela Tuleta, Nikolaos G. Frangogiannis
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113904-113904
Open Access | Times Cited: 87
Isoliquiritigenin mitigates oxidative damage after subarachnoid hemorrhage in vivo and in vitro by regulating Nrf2-dependent Signaling Pathway via Targeting of SIRT1
Jiaqiang Liu, Xintong Zhao, Feiyun Qin, et al.
Phytomedicine (2022) Vol. 105, pp. 154262-154262
Closed Access | Times Cited: 45
Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells
Xuefeng Qu, Bingzhong Zhai, Wenli Hu, et al.
European Journal of Nutrition (2022) Vol. 61, Iss. 4, pp. 1823-1836
Open Access | Times Cited: 38
Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
Mehrdad Hashemi, Mohammad Arad Zandieh, Setayesh Ziaolhagh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 5, pp. 166714-166714
Open Access | Times Cited: 32
Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases
Ziyi Chen, Wenwen Ding, Xiaoxue Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117059-117059
Closed Access | Times Cited: 32
Progress in the treatment of diabetic cardiomyopathy, a systematic review
Yiyi Shou, X M Li, Quan Fang, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Isoliquiritigenin Protects Against Diabetic Nephropathy in db/db Mice by Inhibiting Advanced Glycation End Product–Receptor for Advanced Glycation End Product Axis
Qiwen Shi, Tao Zhou, Wenjun Hou, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Open Access | Times Cited: 1
Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?
Jia-Yue Duan, Xiao Lin, Feng Xu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 51
Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response
Namrita Kaur, Yingshu Guan, Rida Raja, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 48
The licorice flavonoid isoliquiritigenin attenuates Mycobacterium tuberculosis-induced inflammation through Notch1/NF-κB and MAPK signaling pathways
Jinxia Sun, Qingwen Zhang, Gui‐Zhen Yang, et al.
Journal of Ethnopharmacology (2022) Vol. 294, pp. 115368-115368
Closed Access | Times Cited: 34
Nicotinamide mononucleotide increases cell viability and restores tight junctions in high-glucose-treated human corneal epithelial cells via the SIRT1/Nrf2/HO-1 pathway
Qi Pu, Xiaoxiao Guo, Jingjie Hu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112659-112659
Open Access | Times Cited: 33
Activation of Nrf2 signaling: A key molecular mechanism of protection against cardiovascular diseases by natural products
Xiaoyu Wu, Jiajia Wei, Yang Yi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells
Zeyu Wang, Weijian Li, Xue Wang, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 19
Isoliquiritigenin alleviates the development of alcoholic liver fibrosis by inhibiting ANXA2
Na Liu, Min Liu, Mengwei Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114173-114173
Open Access | Times Cited: 16
Protective Effects of Isoliquiritigenin and Licochalcone B on the Immunotoxicity of BDE-47: Antioxidant Effects Based on the Activation of the Nrf2 Pathway and Inhibition of the NF-κB Pathway
Dong Minghui, Ziying Yang, Qian Gao, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 445-445
Open Access | Times Cited: 6
Glycyrrhizae Radix et Rhizoma: The popular occurrence of herbal medicine applied in classical prescriptions
Luying He, Qianming Kang, Yang Zhang, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 7, pp. 3135-3160
Closed Access | Times Cited: 13
The role and therapeutic potential of macrophages in the pathogenesis of diabetic cardiomyopathy
Shan Zhang, Xueying Zhu, Yupeng Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids
Yutong Zhou, Wendong Suo, Xinai Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114025-114025
Open Access | Times Cited: 22
Treatment of diabetic complications: do flavonoids holds the keys?
Rishabh Chalotra, Tanya Gupta, Shivani Chib, et al.
Critical Reviews in Food Science and Nutrition (2023) Vol. 64, Iss. 30, pp. 11091-11112
Closed Access | Times Cited: 12
Impact of inflammation and anti-inflammatory modalities on diabetic cardiomyopathy healing: From fundamental research to therapy
Xiaojiao Zhang, Xiao-Wei Han, Yanhui Jiang, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110747-110747
Closed Access | Times Cited: 12
A combination of isoliquiritigenin with Artemisia argyi and Ohwia caudata water extracts attenuates oxidative stress, inflammation, and apoptosis by modulating Nrf2/Ho‐1 signaling pathways in SD rats with doxorubicin‐induced acute cardiotoxicity
Dennis Jine Yuan Hsieh, Md. Nazmul Islam, Wei‐Wen Kuo, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 12, pp. 3026-3042
Open Access | Times Cited: 11
The mechanisms and therapeutic potential of clopidogrel in mitigating diabetic cardiomyopathy in db/db mice
Bing Li, Yaoting Zhang, Yang Zheng, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109134-109134
Open Access | Times Cited: 4
The combination of berberine and isoliquiritigenin synergistically improved adipose inflammation and obesity‐induced insulin resistance
Xiaoyu Zhang, Lingling Yu, Keke Wang, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 3839-3855
Closed Access | Times Cited: 4
Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF‐κB/NLRP3 Inflammasome Pathway
Yanhong Wang, Jia Yang, Xinyue Chang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 16
Closed Access | Times Cited: 4
Integration of transcriptomics and metabolomics reveals the mechanism of Glycyrrhizae Radix Et Rhizoma extract inhibiting CCL5 in the treatment of acute pharyngitis
Xiaoxiao Han, Chengtao Sun, Hao Ding, et al.
Phytomedicine (2025) Vol. 137, pp. 156360-156360
Closed Access
Page 1 - Next Page

Scroll to top